CTLA4 and neoplasm: Although the dominant mechanism of ɑCTLA-4 is contested, the literature supports that treatment with ɑCTLA-4 improves T cell priming and infiltration into the tumor and increased TdLN exposure of ɑCTLA-4 has been shown to improve therapeutic outcomes65–67.